Page last updated: 2024-08-23

paroxetine and moclobemide

paroxetine has been researched along with moclobemide in 25 studies

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (40.00)	18.2507
2000's	11 (44.00)	29.6817
2010's	4 (16.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
LaBranche, S	1
Hawley, CJ; McPhee, S; Pattinson, HA; Quick, SJ; Ratnam, S	1
König, F; Löble, M; Wolfersdorf, M	1
Cabot, C; Cathala, B; Fabre, M; Robert, P; Senard, JM	1
Jones, GR; Singer, PP	1
Stein, MB	1
Broyer, M; Chamba, G; d'Amato, T; Dalery, J; Ghaemmaghami, C; Lestra, C; Perret-Liaudet, A; Renaud, B	1
FitzSimmons, CR; Metha, S	1
Calabrese, JR; Kimmel, SE; Rapport, DJ; Shelton, MD	1
Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL	1
Bacchiochi, JR; Bagby, RM; Dickens, SE; Eisfeld, BS; Kennedy, SH	1
Baier, D; Kohnen, R; Philipp, M; Tiller, JW	1
Schneier, FR	1
Bagby, RM; Kennedy, SH; Vanderkooy, JD	1
Carpentier, C; Costentin, J; Leroux-Nicollet, I; Naudon, L; Vilpoux, C	1
Amador, XF; Baldini Rossi, N; Cassano, GB; Cassano, P; Dell'Osso, L; Pini, S; Savino, M	1
Deng, JF; Wu, ML	1
Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N	1
Beaulieu, JM; Chahine, M; Poulin, H; Thériault, O	1

Reviews

4 review(s) available for paroxetine and moclobemide

Article	Year
[New antidepressive agents]. L'union medicale du Canada, 1995, Volume: 124, Issue:3 Topics: 1-Naphthylamine; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Child; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Moclobemide; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	1995
Medication treatments for panic disorder and social phobia. Depression and anxiety, 1998, Volume: 7, Issue:3 Topics: Antidepressive Agents, Tricyclic; Benzamides; Benzodiazepines; Citalopram; Clinical Trials as Topic; Clomipramine; Clonazepam; Dose-Response Relationship, Drug; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Piperidines; Recurrence; Selective Serotonin Reuptake Inhibitors; Social Behavior Disorders	1998
Controlled trials in bipolar I depression: focus on switch rates and efficacy. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 9 Suppl 4 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Bipolar Disorder; Controlled Clinical Trials as Topic; Double-Blind Method; Humans; Lamotrigine; Moclobemide; Paroxetine; Triazines	1999
Treatment of social phobia with antidepressants. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 1 Topics: Antidepressive Agents; Controlled Clinical Trials as Topic; Drug Approval; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine; Phenelzine; Phobic Disorders; Piperidines; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; United States	2001

Trials

3 trial(s) available for paroxetine and moclobemide

Article	Year
Safety and tolerability of combined treatment with moclobemide and SSRIs: a systematic study of 50 patients. International clinical psychopharmacology, 1996, Volume: 11, Issue:3 Topics: Adult; Benzamides; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Nausea; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders	1996
Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2000, Volume: 10, Issue:5 Topics: Adult; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires; Time Factors	2000
Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide. International clinical psychopharmacology, 2003, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2003

Other Studies

18 other study(ies) available for paroxetine and moclobemide

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physical binding pocket induction for affinity prediction. Journal of medicinal chemistry, 2009, Oct-08, Volume: 52, Issue:19 Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A	2009
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
[Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis]. Der Nervenarzt, 1996, Volume: 67, Issue:5 Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzamides; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuroleptic Malignant Syndrome; Neurologic Examination; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome; Trimipramine	1996
[Serotonin syndrome in acute poisoning with antidepressive agents]. Annales francaises d'anesthesie et de reanimation, 1996, Volume: 15, Issue:5 Topics: Adult; Antidepressive Agents; Benzamides; Humans; Male; Moclobemide; Muscle Hypertonia; Paroxetine; Serotonin; Syndrome	1996
An uncommon fatality due to moclobemide and paroxetine. Journal of analytical toxicology, 1997, Volume: 21, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Benzamides; Drug Overdose; Fatal Outcome; Gas Chromatography-Mass Spectrometry; Gastrointestinal Contents; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine	1997
Biological parameters in major depression: effects of paroxetine, viloxazine, moclobemide, and electroconvulsive therapy. Relation to early clinical outcome. Biological psychiatry, 1998, Aug-15, Volume: 44, Issue:4 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Benzamides; Biomarkers; Biopterins; Blood Platelets; Depressive Disorder; Drug Resistance; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin; Severity of Illness Index; Treatment Outcome; Viloxazine	1998
Serotonin syndrome caused by overdose with paroxetine and moclobemide. Journal of accident & emergency medicine, 1999, Volume: 16, Issue:4 Topics: Adult; Benzamides; Disease-Free Survival; Drug Overdose; Emergency Treatment; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Suicide, Attempted	1999
Newer antidepressants: a comparison of tolerability in general practice. The British journal of general practice : the journal of the Royal College of General Practitioners, 1999, Volume: 49, Issue:448 Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride	1999
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:4 Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Ontario; Orgasm; Paroxetine; Prevalence; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Sexual Dysfunctions, Psychological; Treatment Outcome; Venlafaxine Hydrochloride	2000
Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:2 Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Bupropion; Canada; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2002
Differential effects of chronic antidepressant treatments on micro- and delta-opioid receptors in rat brain. European journal of pharmacology, 2002, May-17, Volume: 443, Issue:1-3 Topics: Animals; Antidepressive Agents; Autoradiography; Binding Sites; Brain; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Injections, Intraperitoneal; Male; Moclobemide; Morpholines; Paroxetine; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Opioid, delta; Receptors, Opioid, mu; Time Factors	2002
Serotonin toxicity caused by moclobemide too soon after paroxetine-selegiline. Journal of the Chinese Medical Association : JCMA, 2009, Volume: 72, Issue:8 Topics: Female; Humans; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin	2009
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Journal of affective disorders, 2015, Jul-15, Volume: 180 Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2015
Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs. European journal of pharmacology, 2015, Oct-05, Volume: 764 Topics: Analgesics; Antidepressive Agents; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; HEK293 Cells; Humans; Membrane Potentials; Moclobemide; Monoamine Oxidase Inhibitors; NAV1.7 Voltage-Gated Sodium Channel; NAV1.8 Voltage-Gated Sodium Channel; Paroxetine; Patch-Clamp Techniques; Selective Serotonin Reuptake Inhibitors; Sodium Channel Blockers; Time Factors; Transfection	2015